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Background: The final stage of a conventional de-novo cardiac implantable 
electronic device (CIED) implantation procedure with transvenous lead insertion 
involves the formation of a pocket by tissue separation superficial to the pecto-
ralis major muscle in the right or left infraclavicular region, where the device is 
subsequently placed. Over time, a scar “capsule” is formed around the CIED as 
a result of normal biological remodelling.
Materials and methods: The purpose of this study was to analyse the structure 
and present the variations of CIED capsules observed during device replacement. 
The nature and extent of this local tissue remodelling, which had occurred from 
the time of device implantation to its replacement in 2016 (10 ± 3.1 years), was 
analysed in 100 patients (mean age 77.1 ± 14.5 years), including 45 women 
and 55 men.
Results: The most prevalent types of “capsules” (70% of cases) were 
those with similar thickness of both walls or a slightly thicker posterior 
(< 1.0 mm) than anterior wall (< 0.5 mm). The second most common capsule 
type (23% of cases) was characterised by a significantly thicker posterior wall of 
scar tissue (> 1.0 mm). The third group of capsules was characterised by various 
degrees of wall calcification (7% of cases).
Conclusions: The extent and nature of scar tissue structure in the CIED pocket walls 
seem to correlate with the relative position of cardiac lead loops with respect to the 
device itself; where the more extensive scarring is likely to result from pocket wall 
irritation in the capsule formation phase due to lead movements underneath the 
device. The group of cases with calcified capsules was characterised by “old” device 
pockets (> 13 years) and the oldest population (patients in their 80s and 90s). 
(Folia Morphol 2017; 76, 4: 675–681)
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INTRODUCTION
During most of the current cardiac pacemaker 
(PM) and implantable cardioverter-defibrillator (ICD), 
i.e. cardiac implantable electronic device [CIED] im-
plantation procedures, cardiac leads are introduced 
into the venous system via vessels located in the 
deltopectoral triangle. In such situations, the CIED is 
placed in a subcutaneous pocket created superficial 
to the pectoralis major muscle [3, 10]. Creating such 
a pocket involves tissue traumatisation, including 
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damage to myocytes, nerve fibres, and blood vessels, 
as well as blood extravasation. In the months follow-
ing the procedure the histological and morphometric 
parameters of the tissues surrounding the device 
undergo gradual remodelling into a fibrotic capsule.
The course of CIED implantation procedure and 
the time period after device implantation have, it 
seems, a significant effect on the extent of tissue 
remodelling. Moreover, the type of device and leads 
implanted may affect the nature and rate of structural 
and morphometric remodelling [1, 9].
Typically, it is the lead placement inside the heart 
or vessels that has been analysed in terms of cor-
relations between fibrous tissue formation and its 
consequences [5]. Also, a vast majority of literature 
reports on the histomorphology of CIED pockets fo-
cus on secondary pacing system infections and their 
sequelae [11]. The purpose of this paper, however, 
was to visually present and analyse morphohisto-
logic parameters of CIED pockets in non-complicated 
cases. Assessments of the nature of tissue remodel-
ling that had taken place from device implantation 
to its replacement was presented based on our own 
observations.
MATERIALS AND METHODS
A total of 100 consecutive CIED (17 ICDs and 83 
PMs) replacement procedures conducted by the same 
operating personnel at our centre between January 
1, 2016, and October 21, 2016 were included in the 
study (Table 1). 
These procedures were conducted in 45 females 
aged 30–98 (mean 80.1 ± 12.6) years (during device 
replacement) and 55 males aged 41–95 (mean 
75.9 ± 11.9) years (during device replacement).
Each procedure had been dictated by the device 
having reached the elective replacement indication 
phase due to projected battery depletion. Conditions 
that could affect typical capsule formation, such as: 
infections, skin lesions, too superficial subcutane-
ous position of the CIED, etc., were excluded from 
analysis. Neither did we analyse cases following pro-
cedures such as device revision, device up-grade, 
repair procedures, or other procedures whose timing 
and/or extent could considerably affect device pocket 
remodelling.
The analysed procedures were characterised by 
normal device follow-up interrogation values from 
the time of device implantation to its replacement 
due to elective replacement indication.
The device pockets were assessed in terms of their 
morphometric parameters and the type of “capsule-
forming” tissue surrounding the CIED. We distin-
guished three distinct CIED pocket forms (in terms 
of their anterior and posterior wall evaluation) based 
on the following criteria:
Table 1. Cardiac implantable electronic device (CIED) types found during device replacement due to elective replacement indication 
(ERI) (no. of cases); type of arrhythmia detected in electrocardiogram (ECG)/Holter tracings (no. of cases), the period (years) between 
CIED implantation and replacement with pocket revision (PM vs. ICD, p < 0.001), ERI and CIED replacement, and pacemaker depen-
dency: emergence of intrinsic rhythm with the pacing rate lowered to 30 pulses/min, after medication during the procedure
CIED type  
(no. of cases)
Arrhythmia type  
(no. of cases)






PM (83) ECG/Holter PM PM PM
DDD (49) TBS (30)  
AV block (19)
2–24 years  
(mean 10.7 ± 2.8)
DDD: 6–15 years  
(mean 9.4 ± 2.4)
No intrinsic rhythm Æ total  
PM dependency (12)
VVI (29) TBS (18) 
CAF (11)
VVI: 7–13 years  
(mean 11.1 ± 2.9)
AAI (5) SSS (5) AAI: 11–12 years 
(mean 11.4 ± 0.5)
ICD (17) Prevention ICD VR/DR ICD ICD
ICD VR (12) Primary (15)
4–9 years (mean 6.4 ± 1.4)
VR 4–9 years  
(mean 6.6 ± 1.4) Predominantly intrinsic  
rhythm/occasional pacingICD DR (5) Secondary (2) DR 4–7 years  
(mean 5.4 ± 2.7)
PM — pacemaker; DDD — atrioventricular (dual-chamber) pacemaker; VVI — ventricular pacemaker; AAI — atrial pacemaker; ICD VR — single-chamber implantable cardioverter-
-defibrillation; ICD DR — dual-chamber implantable cardioverter-defibrillator; SSS — sick sinus syndrome; TBS — tachycardia-bradycardia syndrome; AV block — second or third degree 
atrioventricular block; CAF — chronic atrial fibrillation
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 — Group I — “typical” pockets, with a thin and 
flexible layer of scar tissue forming the anterior 
(< 0.5 mm) and/or the posterior (< 1.0 mm) wall;
 — Group IIA — pockets with a “typical” anterior wall 
(see above) and the posterior wall characterised 
by localised scar tissue thickening (> 1–2 mm);
 — Group IIB — pockets with a “typical” anterior wall 
(see above) and the (usually entire) posterior wall 
formed of massive scar tissue (> 1–2 mm);
 — Group III — pockets with partial/focal or total 
wall calcification.
Intraoperative qualification of individual cases into 
one of these specific groups has been illustrated in 
the figures of characteristic types of CIED “capsules” 
included in this paper.
All CIED replacement procedures were conducted 
via conventional techniques, with local anaesthesia. 
After opening the device pocket, a visual inspection 
and palpation of its walls were conducted to assess, 
among others, the positions of the leads with respect 
to the device itself. After ascertaining normal lead 
function, supported by device interrogation findings, 
a new device was inserted and connected. In order 
to avoid any potential damage to the lead insulation 
layer during tissue dissection, in some cases a control 
fluoroscopy (posteroanterior view; OEC 9900 Elite 
fluoroscopy system, GE) was conducted immediately 
prior to the procedure.
In patients that were representative for the se-
lected group types, biopsy samples (up to 2 × 4 mm) 
of the pocket wall were collected from the site of its 
incision, towards the end of the procedure, prior to 
device pocket closure. Digital microscopy images of 
collected samples were recorded and linear measure-
ments were made off-line with respect to a 1/10 mm 
(100 μm) micrometric reference scale (Fig. 1C).
The tissue samples were fixed in 4% buffered 
formalin, embedded in paraffin blocks, and sec-
tioned into 4-micrometer sections, deparaffinised 
and stained with haematoxylin-eosin (H&E) and the 
Masson’s trichrome method.
Data on cardiac lead diameter included in fig-
ure captions also help visually assess the amount of 
the surrounding scar tissue. Lead diameter reference 
scale: 1 French unit (1 F) = 0.3333 mm = 0.0131 in.
Our statistical analysis used numerical variables in 
the form of mean values, standard deviations, and 
statistical significance (p-values).
This study had been approved by the Institutional 
Review Board.
RESULTS
Device pocket structure was analysed over 100 
consecutive CIED replacement procedures conducted 
in the analysed time period, which yielded the final 
sample size of: 83 cases of PM pockets in patients 
aged from 30 to 98 years (mean 79 ± 12.8) and 
17 cases of ICD pockets in patients aged from 
63 to 82 years (mean 72 ± 6.8) (mean age difference 
between groups: p = 0.0017). The time period from 
device pocket formation to the assessment of the 
resulting capsule in 2016, ranged from 2 to 24 years 
(mean 10.7 ± 2.8) for PM replacement, and from 
4 to 9 years (mean 6.4 ± 1.4) for ICD replacement 
Figure 1. A–C. Cardiac implantable electronic device (CIED) pocket in an 86-year-old man, during a second device replacement procedure  
13 years after implantation of a DDD-mode pacemaker (Talos DR, Biotronik). The leads are arranged around the CIED margin: an atrial lead 
(SX-53 JBP, Biotronik) and a ventricular lead (CapSure SP Novus, Medtronic); A. Edge of a transected anterior wall of the device capsule 
(white arrows); B. Wrinkled posterior wall of the capsule (black arrows); C. Measure of anterior capsule wall thickness (220-fold magnification).
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procedures. The difference in the mean time period 
between the two types of CIEDs: p < 0.001.
The proportions of the device pocket group types 
based on the structure of their anterior and posterior 
walls, were as follows:
 — Group I — 70% of device capsules were character-
ised by a thin, flexible layer of scar tissue forming 
the anterior and posterior walls of the pocket; this 
was the most common morphometric finding. The 
tissue of the “capsule” could be easily separated 
from the device and/or leads (example: Fig. 1).
 — Subgroup IIA — 18% of capsules were charac-
terised by anterior wall structure similar to that 
specified for group I, i.e. a thin, flexible layer of scar 
tissue, while the posterior wall was characterised by 
localised thickening of tissue surrounding the leads 
located underneath the CIED (example: Fig. 2).
 — Subgroup IIB — 5% of capsules; it was not quite as 
common a finding in terms of posterior pocket wall 
characteristics: flat, massive scar tissue of increased 
density, whose surface area typically corresponded 
to the size of the PM. The anterior wall was usually 
visibly different from a typically structured pocket 
wall (see above) (example: Fig. 3).
 — Group III — 7% of capsules were distinctly dif-
ferent from the other capsule types: they were 
characterised by a hard, calcified structure, 
closely adherent to the CIED, which usually had 
to be manually broken during device replace-
ment, and whose edges were sharp. Among the 
cases analysed here there were those with the 
entire device capsule being calcified, as well as 
those with focal wall calcifications (example: 
Fig. 4).
Figure 2. A–D. Female, 74 years old, first-time pacemaker (PM) (Axios DR, Biotronic) replacement 10 years after implantation; A. Anterior 
wall of the capsule covering the PM after opening the device pocket (arrows); B. Fluoroscopic image: cardiac lead position with respect  
to the PM immediately adjacent to, and a short distance away from, the device; C. The posterior wall of the capsule, with its peripheral structure 
similar to that of the anterior wall (arrows), centrally located focal thickening of scar tissue surrounding a lead segment (CapSure SP Novu,  
6 F, Medtronic) located immediately underneath the PM (white oval); D. Fluoroscopic image: lead position following PM removal.
Figure 3. A, B. Female, 88 years old; pocket walls during second-time SSI-mode pacemaker (PM) replacement (2016) 19 years after a single-
-chamber PM implantation; A. Thin, typical layer of scar tissue forming the anterior wall of the PM capsule (arrows); B. Massive layer of scar 
tissue forming the posterior capsule wall, with an encased cardiac lead loop (oval) (TiR 60-BP, lead diameter 2.2 mm, Biotronik) visible.
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Figure 5. A–D. Histopathological image of cardiac implantable electronic device (CIED) capsules (Figs. 3–5); A. Cell-poor fibrous connective 
tissue. Small clusters of mononuclear cells and numerous vessels are visible, especially in “loose” connective tissue; B. Partly hyalinised fibrous 
connective tissue with sparse cells and occasional foci of calcification; C. Partly hyalinised fibrous connective tissue undergoing calcification 
along the fibres; D. Masson’s (trichrome) staining revealed fibrous connective tissue fibre atrophy and calcification along connective tissue fibres.
Figure 4. A, B. Male, 88 years old, an 18-year-old device pocket with evidence of capsule wall calcification, during a second-time cardiac 
implantable electronic device (CIED) replacement (2016). Leads (SX-JBP Synox and TiR 60-BP, Biotronik) are positioned marginally around  
the pacemaker; A. The entire anterior capsule wall is in the form of a hard calcified plate. Sharp edges of the capsule following its transection 
(arrows); B. Posterior wall: visible calcified “islets” of a lighter colour with respect to other areas of the pocket bed (arrows).
Figure 6. A. Parts of a calcified capsule wall; B. Completely calcified fragment of a device pocket. No collagen fibres, no cellular structures. 
Haematoxylin-eosin staining; magnification ×100.
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No evidence of capsule calcification was observed 
in PM patients under 80 years of age. Group III cap-
sule characteristics were observed in 7 octogenarians 
(mean age 88.5 years); these cases constituted 14% 
of all patients in their 80s (p = 0.019). The presence 
of pocket calcification also correlated with the “age” 
of CIED pockets (> 13 years; mean 13.5 ± 0.8). 
Histopathological evaluation showed capsule va-
riety (Figs. 1–3), which was seen in a vast majority of 
Group I and II patients. Capsule wall structure was 
cell-poor fibrous connective tissue with mononuclear 
cells and a large number of vessels, especially within 
fibrous connective tissue. In Group III, we observed 
focal (Fig. 5 C, D)/planar (Figs. 4, 6) hyalinisation of 
the fibrous tissue with calcification along the fibres.
DISCUSSION
The final stage of a de-novo CIED implantation 
procedure with transvenous lead insertion involves 
the formation of a subcutaneous pocket in the right 
or left infraclavicular region, where the implanted de-
vice is subsequently placed. Pocket formation requires 
mechanical separation of subcutaneous tissues, typi-
cally superficial to the pectoralis major muscle, in an 
area similar to the size of the device being implanted. 
A considerable disproportion in this respect, i.e. the 
size of the pocket being much larger than necessary, 
increases the risk of a haematoma or Twiddler’s syn-
drome [4, 6].
Formation of a “capsule” around the CIED is the 
final stage of normal biological remodelling of tis-
sues damaged during pocket formation. It consists of 
these gradual and overlapping phases: inflammatory 
phase and the phase of scar tissue formation and 
remodelling. Following an injury, the damaged tissue 
is gradually replaced with new granulation tissue. The 
intercellular matrix is replaced with collagen, whose 
haphazardly arranged fibres become organised. The 
cell-rich granulation tissue gradually transforms into 
cell-poor scar tissue [7, 12, 13]. The final stage in-
volves the formation of a scar tissue layer, closely 
adhering to the CIED.
The cases analysed here showed the largest pro-
portion of “capsules” in the form of a thin, flexible 
layer of scar tissue surrounding the whole CIED and 
those with a slightly thicker posterior than the ante-
rior wall. Due to its high prevalence, this capsule type 
(group) was described as typical, with its characteris-
tic flexibility of the scar tissue. If device replacement 
required adapting the pocket size to the slightly dif-
ferent shape of the new CIED, the capsule was easy to 
detach from the adjacent tissues and from the device. 
This type of device pocket was usually accompanied 
by the extravascular lead segments positioned mar-
ginally to the device being replaced, with lead loops 
lying in the same plane as the CIED, neither deeper 
nor more superficial.
The second most common pocket type was char-
acterised by thicker scar tissue underneath the de-
vice, which was accompanied by lead positioning 
underneath the PM. Whenever the lead loops had 
been touching the surface of the CIED either focally 
or with a short segment of their extravascular course, 
only a localised scar capsule thickening was observed 
immediately around the lead, with a typical capsule 
structure in other areas. When long loops of cardiac 
leads had been positioned in one plane underneath 
the CIED, we observed the resulting formation of 
a plate-like mass of hard scar tissue in that plane, 
sometimes encasing the device itself.
A less common CIED capsule variation consisted 
of capsules with evidence of focal or generalised wall 
calcification. Adapting the existing pocket to a new 
device of a slightly different shape required breaking 
the hardened capsule walls, with the calcified frag-
ments exhibiting sharp edges. This type of capsule 
demanded particular attention during CIED replace-
ment in one patient with chronic hepatitis C, due to 
the risk of potential transmission of the pathogen 
to the operating personnel. Pocket calcification may 
also predispose to lead insulation damage, which is 
of particular significance in pacemaker-dependent 
patients.
During CIED implantation procedures the opera-
tor usually arranges the leads around the device. 
However, in some cases lead loops can spontaneously 
migrate to be superficial or deep to the device, which 
results in a more pronounced scar tissue formation. 
A “loose” pocket in the early stage of capsule forma-
tion facilitates movements of extravascular lead seg-
ments and irritation of healing tissues, which, in con-
junction with the blood cells accumulating there, may 
affect the extent and shape of the forming scar tissue.
The components of cardiac lead insulation (polyu-
rethane, silicon rubber) are considered to be compat-
ible with the surrounding biological environment, 
which most likely eliminates them as a potential cause 
of the localised scarring observed in this study [9].
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Pacemaker capsule calcification, in this study ob-
served in patients in their 80s and 90s, with an over 
13-year-old device pocket. Capsule calcification was 
not observed in the case of ICD pockets. However, the 
latter type of CIEDs was found in younger patients 
with shorter time periods to device replacement, for 
reasons including indications for this type of elec-
trotherapy and the devices’ individual use of power.
Formation of massive scar tissue in the pocket 
walls and/or wall calcification make it more difficult 
to isolate leads during device removal as well as to 
implant new leads during device up-date procedures 
[2, 8]. This mechanism of potential lead insulation dam- 
age becomes especially important in patients without 
an intrinsic rhythm, in whom loss of pacing effective-
ness may become immediately life-threatening.
Limitations of the study
For the purposes of this manuscript, the sample 
size was limited to 100 cases, which the authors 
believe to be a representative sample for this type 
of analysis. As the most commonly observed ante-
rior and posterior capsule wall thickness was below 
0.5 mm and 1.0 mm, respectively, these values were 
selected as threshold values differentiating the “nor-
mal” and “thickened” scar tissue layers.
CONCLUSIONS
Morphometric parameters of a formed CIED cap-
sule are significantly affected by spatial relations 
between the device and the extravascular cardiac lead 
segments, where lead loop migration underneath 
the device may facilitate scar tissue formation in the 
posterior wall of the device pocket.
The cases of pocket calcification discovered in our 
patients showed this phenomenon occurring exclu-
sively in the oldest patient group in conjunction with 
“old” device pockets, although calcification was not 
present in all such cases.
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